Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUSAN J STEEN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1649269044
CMS profile
347215
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$61,319.21

384 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Eisai Inc. $26,599.27 28
Otsuka America Pharmaceutical, Inc. $25,070.11 54
Sage Therapeutics, Inc. $1,561.99 13
AbbVie Inc. $1,370.40 29
UCB, Inc. $1,285.40 11
Biogen, Inc. $524.60 18
Celgene Corporation $354.42 20
Teva Pharmaceuticals USA, Inc. $343.45 14
PFIZER INC. $324.47 20
ARGENX US, INC. $322.68 12
Lilly USA, LLC $309.09 13
Octapharma USA, Inc. $278.11 4
Genentech USA, Inc. $261.46 16
Novartis Pharmaceuticals Corporation $250.98 14
Lundbeck LLC $249.26 12
EMD Serono, Inc. $160.13 9
GENZYME CORPORATION $159.10 5
Abbott Laboratories $152.37 2
Amneal Pharmaceuticals LLC $146.09 8
Horizon Therapeutics plc $139.73 7
Alexion Pharmaceuticals, Inc. $138.48 7
GE HEALTHCARE $125.20 8
Takeda Pharmaceuticals U.S.A., Inc. $123.23 4
Amgen Inc. $114.63 6
Acorda Therapeutics, Inc $106.33 4
Neurocrine Biosciences, Inc. $104.34 5
CSL Behring $96.75 5
BANNER LIFE SCIENCES, LLC $85.85 5
TG Therapeutics, Inc. $84.27 4
MDD US Operations, LLC $74.17 4
ACADIA Pharmaceuticals Inc $55.29 3
Sumitomo Pharma America, Inc. $52.77 3
Janssen Pharmaceuticals, Inc $38.49 2
Azurity Pharmaceuticals, Inc. $33.15 2
Boston Scientific Corporation $28.86 2
JAZZ PHARMACEUTICALS INC. $25.76 1
Mallinckrodt Hospital Products Inc. $24.31 1
Almatica Pharma LLC $22.18 1
Astellas Pharma US Inc $18.75 1
Harmony Biosciences LLC $17.01 1
MITSUBISHI TANABE PHARMA AMERICA, INC. $16.78 1
Scilex Pharmaceuticals Inc. $16.55 1
InSightec,Inc $14.42 1
UPSHER-SMITH LABORATORIES LLC $12.92 1
Dynasplint Systems Inc. $12.81 1
Averitas Pharma Inc. $12.80 1

Page 3 of 8; records 101–150 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUSAN J STEEN

NPI 1649269044 · CMS profile ID 347215

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 8; records 101–150 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649269044?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUSAN J STEEN, NPI 1649269044, CMS profile ID 347215. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649269044?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SUSAN J STEEN, NPI 1649269044, CMS profile ID 347215. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 8; records 101–150 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649269044?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SUSAN J STEEN, NPI 1649269044, CMS profile ID 347215, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 8; records 101–150 of 384 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1649269044?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

384 matching records · $61,319.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 384 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 384.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Otsuka America Pharmaceutical, Inc. $1,976.0010/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843417 CMS
TG Therapeutics, Inc. $19.5910/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051475597 CMS
Alexion Pharmaceuticals, Inc. $19.5810/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017026775 CMS
GE HealthCare $22.5910/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039511003 CMS
Biogen, Inc. $19.2010/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012132685 CMS
Neurocrine Biosciences, Inc. $14.5710/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052163013 CMS
Otsuka America Pharmaceutical, Inc. $115.5610/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843387 CMS
Otsuka America Pharmaceutical, Inc. $663.0010/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843369 CMS
Otsuka America Pharmaceutical, Inc. $113.3310/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843379 CMS
Amneal Pharmaceuticals LLC $4.9610/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053539035 CMS
UCB, Inc. $22.1410/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021398851 CMS
Lilly USA, LLC $17.5110/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032277827 CMS
ARGENX US, INC. $23.8710/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060424669 CMS
Celgene Corporation $20.4010/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015048025 CMS
AbbVie Inc. $15.4510/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999108543 CMS
Lilly USA, LLC $23.1510/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032407017 CMS
Neurocrine Biosciences, Inc. $13.5310/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052163007 CMS
Otsuka America Pharmaceutical, Inc. $1,976.0010/11/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843357 CMS
CSL Behring $22.2610/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043031039 CMS
Lundbeck LLC $27.6010/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032373075 CMS
EMD Serono, Inc. $20.0510/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032394829 CMS
PFIZER INC. $16.6210/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049306577 CMS
Otsuka America Pharmaceutical, Inc. $28.8210/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843347 CMS
AbbVie Inc. $19.8510/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999108539 CMS
Amneal Pharmaceuticals LLC $26.5110/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053539031 CMS
Astellas Pharma US Inc $18.7510/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034570629 CMS
Novartis Pharmaceuticals Corporation $20.9610/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993369327 CMS
Novartis Pharmaceuticals Corporation $3.2410/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993369329 CMS
Otsuka America Pharmaceutical, Inc. $28.6810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843327 CMS
Otsuka America Pharmaceutical, Inc. $124.8610/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843337 CMS
PFIZER INC. $13.0810/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049419440 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.5510/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055621149 CMS
Eisai Inc. $99.6209/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023334275 CMS
Horizon Therapeutics plc $28.6209/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 987079553 CMS
Otsuka America Pharmaceutical, Inc. $5.0009/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843291 CMS
Otsuka America Pharmaceutical, Inc. $7.8609/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843301 CMS
Otsuka America Pharmaceutical, Inc. $1,976.0009/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843311 CMS
Otsuka America Pharmaceutical, Inc. $52.4009/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843319 CMS
TG Therapeutics, Inc. $19.5909/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051475527 CMS
Otsuka America Pharmaceutical, Inc. $1,976.0009/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843281 CMS
MDD US Operations, LLC $17.7109/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052896075 CMS
Otsuka America Pharmaceutical, Inc. $119.1209/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843273 CMS
Teva Pharmaceuticals USA, Inc. $10.3109/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056728363 CMS
AbbVie Inc. $63.7509/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999108535 CMS
Dynasplint Systems Inc. $12.8109/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 969648001 CMS
Sumitomo Pharma America, Inc. $19.3709/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030752419 CMS
Azurity Pharmaceuticals, Inc. $15.4009/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989001701 CMS
Eisai Inc. $21.8509/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023334287 CMS
Octapharma USA, Inc. $73.7509/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042736219 CMS
Otsuka America Pharmaceutical, Inc. $1,976.0009/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014843263 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $22,791.99 334
PY2020 $30,002.04 316
PY2021 $39,620.67 363
PY2022 $33,647.18 348
PY2023 $61,319.21 384
PY2024 $108,119.44 149
PY2025 $45,759.91 68

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,041,644.37 22
PY2024 Recipient $2,603.10 1
PY2024 Principal investigator $434,042.60 28
PY2023 Recipient $355.00 1
PY2023 Principal investigator $957,686.21 18
PY2022 Recipient $2,022.00 2
PY2022 Principal investigator $1,746,890.90 18
PY2021 Recipient $5,196.00 1
PY2021 Principal investigator $1,454,203.20 20
PY2020 Recipient $3,718.74 2
PY2020 Principal investigator $908,433.07 35
PY2019 Principal investigator $622,280.47 42

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $5,584.00 11/25/2025 Non-covered Recipient Entity
Axiom Brain Health LLC
Alzheimer's Disease Master Pre Screener No dispute reported 06/30/2026 1211576746
Principal investigator 1 Genentech, Inc. $163,672.00 11/25/2025 Non-covered Recipient Entity
Axiom Brain Health LLC
Alzheimer's Disease Master Pre Screener No dispute reported 06/30/2026 1211576750
Principal investigator 1 Novo Nordisk AS $4,292.32 10/29/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213750873
Principal investigator 1 Genentech, Inc. $13,500.00 10/28/2025 Non-covered Recipient Entity
Axiom Brain Health LLC
Alzheimer's Disease Master Pre Screener No dispute reported 06/30/2026 1211576737
Principal investigator 1 Genentech, Inc. $51,896.00 10/14/2025 Non-covered Recipient Entity
Axiom Brain Health LLC
Alzheimer's Disease Master Pre Screener No dispute reported 06/30/2026 1211576741
Principal investigator 1 Genentech, Inc. $17,964.00 09/24/2025 Non-covered Recipient Entity
Axiom Brain Health LLC
Alzheimer's Disease Master Pre Screener No dispute reported 06/30/2026 1211576733
Principal investigator 1 Novo Nordisk AS $527.40 09/19/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213709454
Principal investigator 1 Novo Nordisk AS $190.00 09/19/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213719058
Principal investigator 1 Eli Lilly and Company $16,028.00 08/25/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH LLC
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187874831
Principal investigator 1 Novo Nordisk AS $812.25 08/22/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213757053
Principal investigator 1 Novo Nordisk AS $11,823.87 06/23/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213718300
Principal investigator 1 Novo Nordisk AS $2,500.00 05/07/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213779437
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,800.00 04/04/2025 Non-covered Recipient Entity
Advarra
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235999229
Principal investigator 1 Novo Nordisk AS $812.25 03/28/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213712955
Principal investigator 1 Eli Lilly and Company $2,386.00 02/25/2025 Non-covered Recipient Entity
AXIOM CLINICAL RESEARCH OF FLORIDA
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187874833
Principal investigator 1 Eli Lilly and Company $413,696.00 02/25/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH LLC
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187875281
Principal investigator 1 Eli Lilly and Company $226.00 02/25/2025 Non-covered Recipient Entity
AXIOM CLINICAL RESEARCH OF FLORIDA
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE No dispute reported 06/30/2026 1187880879
Principal investigator 1 UCB SA $9,051.00 02/25/2025 Non-covered Recipient Entity
Axiom Brain Health
A MULTICENTER PHASE 2, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF UCB0022 IN STUDY PARTICIPANTS WITH ADVANCED Parkinsons DISEASE No dispute reported 06/30/2026 1246659356
Principal investigator 1 Novo Nordisk AS $2,152.80 02/21/2025 Non-covered Recipient Entity
AXIOM BRAIN HEALTH
NN6535-4725 No dispute reported 06/30/2026 1213791479
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,003.74 01/27/2025 Non-covered Recipient Entity
Axiom Brain Health
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235998808
Principal investigator 1 Eli Lilly and Company $6,199.74 01/24/2025 Non-covered Recipient Entity
AXIOM CLINICAL RESEARCH OF FLORIDA
A STUDY OF REMTERNETUG VERSUS PLACEBO IN EARLY ALZHEIMER'S DISEASE PARTICIPANTS AT RISK FOR COGNITIVE AND FUNCTIONAL DECLINE No dispute reported 06/30/2026 1187876385
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $310,527.00 01/16/2025 Non-covered Recipient Entity
Axiom Brain Health
A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimers Disease (TargetTau-1) No dispute reported 06/30/2026 1235998806